Mesa Laboratories, Inc.: Expect to Record Non-Cash Impairment Losses Related to Clinical Genomics and Biopharmaceutical Development Divisions of About $271M During 4Q FY24 >MLAB
Mesa Laboratories, Inc.: Expect to Record Non-Cash Impairment Losses Related to Clinical Genomics and Biopharmaceutical Development Divisions of About $271M During 4Q FY24 >MLAB
Mesa Laboratories, Inc.：预计将在24财年第四季度记录与临床基因组学和生物制药开发部门相关的非现金减值损失约2.71亿美元 >MLAB
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册